Skin cancer in non‐white liver transplant recipients: Mayo Clinic experience. (20th March 2021)

• Record Type: Journal Article
• Authors: Tolaymat, Leila M.; Reimer, Danielle K.; Feig, Joshua; Gillis, Melinda S.; Speicher, Leigh L.; Haga, Claire B.; Gabriel, Emmanuel M.; Heckman, Michael G.; Yin, Mingyuan; Fosko, Scott W.; Keaveny, Andrew P.; Dawson, Nancy L.
• Is Part Of: International journal of dermatology. Volume 60:Number 8(2021)
• Page Start: 986
• Page End: 990
• Publication Date: 2021-03-20
• Subjects: Dermatology -- Periodicals; 616.5
• DOI: 10.1111/ijd.15519
• Languages: English
• ISSNs: 0011-9059

Abstract

Abstract: Background: Limited data are available on the development of skin cancer and the associated risk factors for non‐White liver transplant (LT) recipients. The aim of this study is to determine the incidence of newly diagnosed skin cancer postoperatively and to identify the risk factors for the development of skin cancer in non‐White LT recipients. Methods: We conducted an initial retrospective chart review of non‐White LT patients who received a transplant at our center between January 1, 2011, and December 31, 2013. Results: Of the 96 patients in the study cohort, 32% were Black, 17% were Asian, 15% were White Hispanic, and 10% were Black Hispanic. One patient had a history of nonmelanoma skin cancer before transplant. No skin cancers were diagnosed during follow‐up (median, 1.3 years; range, 17 days to 8.6 years). Conclusion: Our center's experience is consistent with the literature and suggests that the incidence of newly diagnosed skin cancer in non‐White liver transplant recipients is low. Longer follow‐up may provide additional insights into the specific risk factors for the posttransplant development of skin cancer.